Prognostic Impact of the Initial Postoperative CA19-9 Level in Patients with Extrahepatic Bile Duct Cancer

被引:0
作者
Yuichiro Kato
Shinichiro Takahashi
Naoto Gotohda
Masaru Konishi
机构
[1] National Cancer Center Hospital East,Division of Hepatobiliary Pancreatic Surgery
来源
Journal of Gastrointestinal Surgery | 2016年 / 20卷
关键词
Bile duct cancer; Cholangiocarcinoma; CA19-9; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1435 / 1443
页数:8
相关论文
共 95 条
  • [1] Akoad M(2008)Proximal biliary malignancy Surg Clin North Am. 88 1409-28
  • [2] Jenkins R(2001)Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma Ann Surg. 234 507-17
  • [3] Jarnagin WR(2008)Distal biliary malignancy Surg Clin North Am. 88 1429-47
  • [4] Fong Y(2009)Evidence-based approach to cholangiocarcinoma: a systematic review of the current literature J Am Coll Surg. 208 134-47
  • [5] DeMatteo RP(1981)Specific antigen in serum of patients with colon carcinoma Science. 212 53-5
  • [6] Gonen M(1979)Colorectal carcinoma antigens detected by hybridoma antibodies Somatic Cell Genet. 5 957-71
  • [7] Burke EC(1998)CA 19-9 as a marker for gastrointestinal cancers: a review Ann Clin Biochem 35 364-70
  • [8] Bodniewicz BJ(2010)Elevated CA 19-9 portends poor prognosis in patients undergoing resection of biliary malignancies HPB (Oxford). 12 134-8
  • [9] Veillette G(1999)Diagnostic and prognostic values of CA 19-9 and CEA in periampullary cancers J Am Coll Surg. 188 415-20
  • [10] Castillo CF(2010)Serum carbohydrate antigen (CA) 19-9 as a prognostic factor in cholangiocarcinoma: a meta-analysis Front Med China. 4 457-62